Imricor Medical Systems Begins US Commercial Launch with Sale of iMR Mapping, Guidance System

MT Newswires Live07-27 08:18

Imricor Medical Systems (ASX:IMR) began its official US commercial launch, with the Rady Children's Hospital in San Diego, California, purchasing its NorthStar interventional magnetic resonance (iMR) mapping and guidance system, according to a Monday Australian bourse filing.

It also launched a new vertical, Imricor Cardiovascular, for the NorthStar system. It expects to continue adding devices and applications within the Cardiovascular business over time.

Several US hospitals are in the final stages of the purchasing process, the filing added. Revenue from the NorthStar sales is expected to exceed the European business' aggregate full-year revenue in 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment